← All Sponsors

SPONSOR

First Affiliated Hospital of Zhejiang University

Total Trials

12

Recruiting

12

Phases

Phase 2, Phase 1

Conditions studied: Pheochromocytoma Immune Evasion, Tumor Pancreas Cancer Leukemia Relapse Hematological Malignancies Marginal Zone Lymphoma Major Depressive Disorder Major Depressive Disorder, Recurrent ADHD

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

Pheochromocytoma

Construction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution

Immune Evasion, Tumor

NCT07105579 Phase 2

Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia

18F-Pentixafor PET in Hematologic Malignancies

Hematological Malignancies

NCT06504940 Phase 2

Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL)

Marginal Zone Lymphoma

Accelerated Intermittent Theta-Burst Stimulation Ameliorate Major Depressive Disorder by Regulating CAMKII Pathway

Major Depressive Disorder

Effect of iTBS on Children With ADHD

NCT06682195 Phase 2

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

TNBC, Triple Negative Breast Cancer

Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

Graft vs Host Disease

NCT06874933 Phase 2

Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03)

HR+/HER2- Breast Cancer

NCT07321626 Phase 1

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Acute Myeloid Leukemia

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

Multiple Myeloma